Burns stored fat, blocks new fat
AOD-9604 stimulates lipolysis to break down stored fat and inhibits lipogenesis to slow new fat storage — it attacks the problem from both sides, targeting adipose tissue directly.
Back to all peptides
Unavailable
AOD 9604 Injection
Pure Fat Burning Peptide
Energy
A growth hormone fragment engineered specifically for targeted fat metabolism.
- Targeted fat reduction without hormonal effects
- No impact on blood sugar or IGF-1 levels
- Supports sustainable weight management
- Promotes lipolysis in adipose tissue
- Does not affect appetite or muscle mass
Dosage3mg/mL, 5mL vial
AdministrationSubcutaneous injection
Compounded in the U.S.A.
Temporarily unavailable from our compounding pharmacy. Check back soon.
About
What is AOD 9604?
AOD-9604 is the fat-burning fragment of human growth hormone — amino acids 176–191 — isolated on its own. It was engineered to keep GH's effect on fat metabolism while leaving out the parts that raise blood sugar, raise IGF-1, or trigger growth. The FDA granted GRAS (Generally Recognized as Safe) status for the oral form.
Mechanically it works both sides: AOD-9604 stimulates lipolysis (breaking stored fat into free fatty acids your body can burn) and inhibits lipogenesis (making new fat). It targets adipose tissue directly — including stubborn abdominal fat — and because it does not trigger catabolic pathways, lean muscle stays intact. No stimulant jitters, no appetite suppression, no insulin disruption.
PeRx ships AOD-9604 fully reconstituted from an FDA-registered 503A pharmacy. No mixing — insulin syringes and a step-by-step guide arrive in the box. It is a subcutaneous injection, typically in the morning, on a provider-determined schedule.
Why do people explore AOD 9604 therapy?
Targets lipolysis in the abdominal area specifically — the stored fat that diet and exercise alone struggle to shift.
No blood sugar impact, no insulin disruption. Targeted fat loss without the metabolic baggage of full growth hormone.
Muscle stays intact while fat drops. AOD-9604 targets adipose tissue without the catabolic effects that strip lean mass.
No jitters, no crashes, no appetite suppression. Fat metabolism happens at the cellular level, not through stimulant force.
Well-tolerated in clinical trials, with FDA GRAS status confirming its safety profile for long-term use.
Why people explore AOD 9604
A clearer path forward.
Fat loss without the hormonal baggage
It isolates only the fat-metabolism fragment of GH (amino acids 176–191), so you get the fat-burning without the blood-sugar, IGF-1, or growth side effects of full growth hormone.
The FDA granted GRAS (Generally Recognized as Safe) status for the oral form.
Muscle stays put
Unlike calorie restriction or stimulant fat-burners, AOD-9604 doesn't activate catabolic pathways that break down lean tissue — so the fat drops while the muscle holds. No jitters, no crash, no appetite suppression.
What it helps with
Designed for these concerns.
- Targeted fat reduction without hormonal effects
- No impact on blood sugar or IGF-1 levels
- Supports sustainable weight management
- Promotes lipolysis in adipose tissue
- Does not affect appetite or muscle mass
Ideal for
Those seeking fat loss without hormonal effects · Adults wanting targeted abdominal fat reduction · Those who want fat loss without affecting muscle mass · Individuals looking for a non-stimulant approach
The science
How AOD 9604 works.
AOD 9604 mimics the fat-reducing action of growth hormone without affecting blood sugar or IGF-1 levels. It stimulates lipolysis and inhibits lipogenesis, targeting fat metabolism directly.
01
Signal
AOD-9604 is given as a subcutaneous injection, typically in the morning, on a provider-determined schedule.
02
Cellular response
AOD-9604 mimics the fat-reducing action of growth hormone without affecting blood sugar or IGF-1. It stimulates lipolysis and inhibits lipogenesis, targeting fat metabolism directly while sparing lean muscle.
03
Outcome
Over the following weeks most people notice subtle metabolic shifts and reduced bloating first (weeks 1–2), then more noticeable body-composition change around the midsection (weeks 2–4), then visible fat loss with muscle preserved (weeks 4–8), with the best results from week 8 onward — diet and exercise still do the heavy lifting.
Subcutaneous injectionCompounded in the U.S.A. at a 503A pharmacyProvider-prescribed
What the research shows
Backed by published science.
176–191
The GH amino-acid fragment AOD-9604 isolates
GRAS
FDA Generally-Recognized-As-Safe status (oral form)
0
Effect on blood glucose, IGF-1, or muscle mass in trials
4–8 wks
When visible fat loss typically becomes apparent
- FDA granted GRAS status for oral form
- Studies show significant abdominal fat reduction
- No impact on insulin sensitivity or IGF-1
- Well-tolerated in clinical trials
Lab tested medications
for quality & potency
Our medication is delivered from a state-licensed pharmacy in our network, right to your door when you need it.
Third-party quality control testing
Compounded in U.S. pharmacies
Lab tested for quality & potency
Our pharmacies perform third-party testing through FDA and DEA registered labs to run quality control checks for every compounded lot. They test four key characteristics associated with quality and safety.
Potency Test
PassedPerformed on every batch to confirm the active ingredient is present at the labeled concentration. Your vial contains exactly what it should.
Sterility Test
PassedTests for the presence of bacteria, fungi, and other microorganisms. Every batch is tested and must meet the requirements of USP 797.1.
Endotoxin Test
PassedScreens for bacterial endotoxins that can cause fever or adverse reactions. Every batch is tested and must not exceed the threshold limits defined in USP 85.
pH Test
PassedAssesses the acid/base balance to ensure minimal irritation upon injection and confirm the solution is within the correct range for subcutaneous administration.
What to expect
Your AOD 9604 timeline.
- 01
Week 1–2
Metabolic priming
What you may notice: Subtle changes in how your body handles energy. Some people notice reduced bloating and a slight shift in how clothes fit around the midsection.
What’s happening: AOD-9604 is activating lipolysis in adipose tissue and beginning to inhibit new fat storage. The metabolic shift is underway.
- 02
Week 2–4
Fat mobilization
What you may notice: More noticeable changes in body composition, particularly around the abdomen. Energy levels may improve as your body gets better at burning fat for fuel.
What’s happening: Stored fat is being broken down into free fatty acids at an accelerated rate. Lipogenesis inhibition means fewer new fat deposits are forming.
- 03
Week 4–8
Visible results
What you may notice: Clear improvements in body composition. The midsection tightens. Workout results improve because your body is using fat more efficiently as fuel.
What’s happening: Sustained lipolysis is producing measurable fat loss. Muscle mass remains preserved because AOD-9604 does not trigger catabolic pathways.
- 04
Week 8–12+
Optimization
What you may notice: Best results typically appear in this window. Many people feel leaner and more defined than they have in years.
What’s happening: Weeks of targeted fat metabolism reach their peak. Your provider may adjust the protocol based on your results.
Comparison
AOD 9604 vs. MOTS-c
Both work on fat metabolism — here's the difference.
| AOD 9604 | MOTS-c | |
|---|---|---|
| Best for | Pure fat burning, no growth effects | Metabolic optimization, exercise capacity, insulin sensitivity |
| How it works | A GH fragment — drives lipolysis and blocks lipogenesis | A mitochondrial peptide — activates AMPK (the exercise/fasting switch) |
| Scope | Targeted — focuses on adipose tissue | Systemic — improves overall metabolic health |
| Best if you want | Targeted fat reduction without hormonal effects | Cellular energy and exercise-mimetic benefits |
| Can combine? | Yes — pairs well with MOTS-c (also sold as a combo vial) | Yes — pairs well with AOD-9604 |
FAQ
Common questions about AOD 9604.
Patient reviews
What patients are saying.
No reviews yet. Be the first verified patient to share your experience.
This is not medical advice. Every patient's experience differs and not everyone qualifies for peptide therapy. All reviews are from verified PeRx patients and are published as submitted. Peptide therapy requires a valid prescription from a licensed provider.
Your safety, first
Important safety information.
- Generally well tolerated
- Possible injection site reactions
- Should not be used during pregnancy
- Requires licensed provider supervision
All prescriptions are issued by a licensed US provider after reviewing your intake.
Side effects, contraindications, and what to discuss with your provider before starting.
Read safety informationSupporting research
Selected studies.
A selection of peer-reviewed work on AOD 9604. Browse the full literature on PubMed and Google Scholar for ongoing research.
Fat reduction without growth effects
Heffernan MA et al. Obes Res. 2001;9(12):813–819.Human clinical trial
Stier H et al. J Endocrinol Metab. 2004.GRAS safety assessment
Stier H et al. Regul Toxicol Pharmacol. 2015;72(2):358–364.
The statements on this page have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The FDA does not review or approve compounded medications for safety or effectiveness. Off-label use must be prescribed and supervised by a licensed provider.
You may also be interested in
Pairs well with.
Keep exploring
Learn more about AOD 9604
Last updated April 2026
Medical disclaimer
The information provided on this page is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. Peptide therapy requires a valid prescription from a licensed healthcare provider. Individual results may vary. No specific outcomes are guaranteed.
The peptides on this site are not FDA-approved. They are compounded by licensed pharmacies under provider supervision. Certain peptides are prohibited by WADA and major sports organizations. Statements on this page have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease.
Ready to start with AOD 9604?
Take our 2-minute assessment. A licensed US provider reviews and, if appropriate, prescribes a protocol shipped to your door.